-
1
-
-
33646255654
-
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan
-
Barst RJ, Langleben D, Badesch D, et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 2006; 47: 2049-2056.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 2049-2056
-
-
Barst, R.J.1
Langleben, D.2
Badesch, D.3
-
2
-
-
33846247928
-
Sitaxsentan Treatment for Patients with Pulmonary Arterial Hypertension Discontinuing Bosentan
-
DOI 10.1016/j.healun.2006.10.019, PII S1053249806007741
-
Benza RL, Mehta S, Keogh A, et al. Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan. J Heart Lung Transplant 2007; 26: 63-69. (Pubitemid 46096748)
-
(2007)
Journal of Heart and Lung Transplantation
, vol.26
, Issue.1
, pp. 63-69
-
-
Benza, R.L.1
Mehta, S.2
Keogh, A.3
Lawrence, E.C.4
Oudiz, R.J.5
Barst, R.J.6
-
3
-
-
40649084619
-
Endothelin receptor antagonists in pulmonary arterial hypertension
-
Dupuis J, Hoeper MM. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008; 31: 407-415.
-
(2008)
Eur Respir J
, vol.31
, pp. 407-415
-
-
Dupuis, J.1
Hoeper, M.M.2
-
4
-
-
0036283401
-
Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: Open-label pilot study
-
DOI 10.1378/chest.121.6.1860
-
Barst RJ, Rich S, Widlitz A, et al. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. Chest 2002; 121: 1860-1868. (Pubitemid 34634407)
-
(2002)
Chest
, vol.121
, Issue.6
, pp. 1860-1868
-
-
Barst, R.J.1
Rich, S.2
Widlitz, A.3
Horn, E.M.4
McLaughlin, V.5
McFarlin, J.6
-
5
-
-
69249146238
-
Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy
-
Hoeper MM, Olsson KM, Schneider A, et al. Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy. Eur Respir J 2009; 33: 1518-1519.
-
(2009)
Eur Respir J
, vol.33
, pp. 1518-1519
-
-
Hoeper, M.M.1
Olsson, K.M.2
Schneider, A.3
-
6
-
-
70349091119
-
Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
-
Lavelle A, Sugrue R, Lawler G, et al. Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension. Eur Respir J 2009; 34: 770-771.
-
(2009)
Eur Respir J
, vol.34
, pp. 770-771
-
-
Lavelle, A.1
Sugrue, R.2
Lawler, G.3
-
7
-
-
0031045468
-
The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs
-
Garcia Rodriguez LA, Wallander MA, Stricker BH. The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs. Br J Clin Pharmacol 1997; 43: 183-188.
-
(1997)
Br J Clin Pharmacol
, vol.43
, pp. 183-188
-
-
Garcia Rodriguez, L.A.1
Wallander, M.A.2
Stricker, B.H.3
-
8
-
-
34249821036
-
Risk of acute liver injury associated with the use of drugs: A multicentre population survey
-
DOI 10.1111/j.1365-2036.2007.03338.x
-
Sabate M, Ibanez L, Perez E, et al. Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther 2007; 25: 1401-1409. (Pubitemid 46848892)
-
(2007)
Alimentary Pharmacology and Therapeutics
, vol.25
, Issue.12
, pp. 1401-1409
-
-
Sabate, M.1
Ibanez, L.2
Perez, E.3
Vidal, X.4
Buti, M.5
Xiol, X.6
Mas, A.7
Guarner, C.8
Forne, M.9
Sola, R.10
Castellote, J.11
Rigau, J.12
Laporte, J.-R.13
-
9
-
-
57249086242
-
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States
-
Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-1934.
-
(2008)
Gastroenterology
, vol.135
, pp. 1924-1934
-
-
Chalasani, N.1
Fontana, R.J.2
Bonkovsky, H.L.3
-
10
-
-
3142557936
-
Acute and clinically relevant drug-induced liver injury: A population case-control study
-
DOI 10.1111/j.1365-2125.2004.02133.x
-
de Abajo FJ, Montero D, Madurga M, et al. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 2004; 58: 71-80. (Pubitemid 38901470)
-
(2004)
British Journal of Clinical Pharmacology
, vol.58
, Issue.1
, pp. 71-80
-
-
De Abajo, F.J.1
Montero, D.2
Madurga, M.3
Garcia, R.L.A.4
-
11
-
-
70349088094
-
Liver toxicity: The Achilles' heel of endothelin receptor antagonist therapy?
-
Hoeper MM. Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy? Eur Respir J 2009; 34: 529-530.
-
(2009)
Eur Respir J
, vol.34
, pp. 529-530
-
-
Hoeper, M.M.1
-
12
-
-
84866489825
-
-
Date last updated: August 3, Date last accessed: August 3, 2010
-
The electronic Medicines Compendium (eMC). www.medicines.org.uk. Date last updated: August 3, 2010. Date last accessed: August 3, 2010.
-
(2010)
The Electronic Medicines Compendium (eMC)
-
-
-
13
-
-
70350228380
-
Diagnosis, management and prevention of drug-induced liver injury
-
Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut 2009; 58: 1555-1564.
-
(2009)
Gut
, vol.58
, pp. 1555-1564
-
-
Verma, S.1
Kaplowitz, N.2
-
14
-
-
70349406480
-
Current concepts of mechanisms in drug-induced hepatotoxicity
-
Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009; 16: 3041-3053.
-
(2009)
Curr Med Chem
, vol.16
, pp. 3041-3053
-
-
Russmann, S.1
Kullak-Ublick, G.A.2
Grattagliano, I.3
-
15
-
-
42249102412
-
Acute liver failure: Summary of a workshop
-
DOI 10.1002/hep.22177
-
Lee WM, Squires RH Jr, Nyberg SL, et al. Acute liver failure: summary of a workshop. Hepatology 2008; 47: 1401-1415. (Pubitemid 351547926)
-
(2008)
Hepatology
, vol.47
, Issue.4
, pp. 1401-1415
-
-
Lee, W.M.1
Squires Jr., R.H.2
Nyberg, S.L.3
Doo, E.4
Hoofnagle, J.H.5
-
16
-
-
34547558919
-
Results of European post-marketing surveillance of bosentan in pulmonary hypertension
-
DOI 10.1183/09031936.00138706
-
Humbert M, Segal ES, Kiely DG, et al. Results of European post-marketing surveillance of bosentan in pulmonary hypertension. Eur Respir J 2007; 30: 338-344. (Pubitemid 47194187)
-
(2007)
European Respiratory Journal
, vol.30
, Issue.2
, pp. 338-344
-
-
Humbert, M.1
Segal, E.S.2
Kiely, D.G.3
Carlsen, J.4
Schwierin, B.5
Hoeper, M.M.6
|